Jon Bliley focuses his practice on mergers and acquisitions and other commercial transactions involving companies from numerous industries, including long-term care, financial services and government contracting.  Jon helps clients navigate all aspects of commercial transactions and general corporate matters, including corporate finance, securities laws and corporate governance.

Jon Bliley focuses his practice on mergers and acquisitions and other commercial transactions involving companies from numerous industries, including long-term care, financial services and government contracting.  Jon helps clients navigate all aspects of commercial transactions and general corporate matters, including corporate finance, securities laws and corporate governance.

Jon’s broad experience includes mergers and acquisitions of all sizes, tender offers, cross-border transactions, joint venture arrangements, fund formations and recapitalizations. He has worked with growth companies seeking to expand their businesses, raise venture or other private capital and consummate exit transactions. Jon has also assisted clients with Hart-Scott-Rodino (HSR) Act analysis and filings in connection with mergers and acquisitions.

In addition, Jon has represented publicly traded companies in connection with their reporting obligations under the Securities Exchange Act of 1934 and NYSE and NASDAQ listing requirements.

Jon is a member of the board of trustees for Historic Richmond and the board of trustees for The Menokin Foundation. He is also a member of the Mergers and Acquisitions Committee of the American Bar Association, and he served on the working group for the ABA Carveout Transactions 2016 Deal Points Study.  Before joining Williams Mullen, Jon was an associate in the corporate section at Cadwalader, Wickersham & Taft, LLP in New York.

Jon received his J.D., cum laude, from the University of Maryland School of Law, where he won the Joseph Bernstein Prize for submitting the most significant piece of legal writing for publication in The Journal of Business & Technology Law. He received his B.A., cum laude, from Vanderbilt University. He is admitted to practice law in New York and Virginia.

  • Assisted a Virginia-based carrier owning more than 400 trucks and operations throughout the U.S. and Canada in the sale of the company and related entities to the largest full truckload carrier in North America.

  • Assisted a private equity sponsor with acquisitions of long-term care portfolios and dispositions of long-term care facilities.

  • Assisted a private equity sponsor with the negotiation of joint venture agreements and other documents related to raising equity capital for the acquisition of long-term care portfolios.

  • Assisted a commercial real estate fund in connection with a dividend recapitalization structured as a preferred equity investment by an institutional investor.

  • Assisted a commercial real estate fund in connection with the recapitalization of a distressed portfolio.

  • Assisted a private equity fund in the sale of its long-term care campus to a nonprofit corporation.

  • Assisted a buyer with the cross-border acquisition of an international supply chain management services company based in Switzerland, with subsidiaries located in Germany and the United Arab Emirates.

  • Assisted a buyer with the cross-border acquisition of a cash processing company based in Italy, with subsidiaries located in England, Scotland and the United States.

  • Assisted founding principals in the sale of their contingent labor management services company to a portfolio company of a private equity fund.

  • Assisted a private equity firm in minority investment in an engineering technology firm.

  • Assisted an investment bank with the sale of its equity interests in a prominent gaming company.

  • Assisted a regional public utility company in merger with Fortune 200 electrical power company.

  • Assisted a pharmaceutical company with the cross-border divestiture of a manufacturing business to a private equity fund.

  • Assisted a pharmaceutical company with its acquisition of a global pharmaceutical company through a two-step merger.

  • Assisted a pharmaceutical company in connection with a tender offer for its outstanding convertible senior notes.

  • Assisted a pharmaceutical company with its acquisition of a global pharmaceutical company in a cash-and-stock merger.

  • Representation of public companies in connection with their reporting obligations under the Securities Exchange Act of 1934 and NYSE and NASDAQ listing requirements.

Note: Certain of the above representations were handled prior to joining Williams Mullen.